Description

5-((4-(2-(5-Methyl-2-Phenyloxazol-4-Yl)Ethoxy)Benzo[B]Thiophen-7-Yl)Methyl)Thiazolidine-2,4-Dione is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound matters as a critical building block in the research and development of novel therapeutic agents, particularly targeting metabolic and inflammatory pathways. It is primarily needed by pharmaceutical R&D laboratories, contract research organizations (CROs), and fine chemical manufacturers engaged in synthesizing next-generation drug candidates.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the synthesis of investigational new drugs (INDs), particularly thiazolidinedione-based compounds.
• Research & Development: Used in academic and industrial research for studying structure-activity relationships (SAR) and biological activity in medicinal chemistry programs.
• Metabolic Disorder Research: Applied in the development of potential therapeutic agents for conditions like type 2 diabetes, due to its thiazolidine-2,4-dione core.
• Anti-inflammatory Agent Development: Investigated for its potential role in creating novel anti-inflammatory pharmaceuticals.
• Chemical Biology Probes: Utilized as a specialized tool compound for probing specific biological targets and pathways in cellular assays.
• Process Chemistry: Employed in scale-up and optimization studies for the commercial production of active pharmaceutical ingredients (APIs).

Basic Information

Product Name	5-((4-(2-(5-Methyl-2-Phenyloxazol-4-Yl)Ethoxy)Benzo[B]Thiophen-7-Yl)Methyl)Thiazolidine-2,4-Dione
CAS No.	213411-83-7
Molecular Formula	C24H20N2O4S2
Molecular Weight	464.56 g/mol
Synonyms	5-[[4-[2-(5-Methyl-2-phenyl-4-oxazolyl)ethoxy]-1-benzothiophen-7-yl]methyl]-2,4-thiazolidinedione; 5-((4-(2-(5-Methyl-2-phenyloxazol-4-yl)ethoxy)benzo[b]thiophen-7-yl)methyl)thiazolidine-2,4-dione; TZD Derivative; Benzothiophene-Oxazole-Thiazolidinedione Hybrid; 213411-83-7; 5-[(4-{2-[5-Methyl-2-phenyl-1,3-oxazol-4-yl]ethoxy}-1-benzothiophen-7-yl)methyl]-1,3-thiazolidine-2,4-dione
EINECS	Contact for details

Quality Control

Our 5-((4-(2-(5-Methyl-2-Phenyloxazol-4-Yl)Ethoxy)Benzo[B]Thiophen-7-Yl)Methyl)Thiazolidine-2,4-Dione is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods (NMR, IR, MS), to ensure it meets the high standards required for pharmaceutical research. Certificates of Analysis (COA) detailing all specifications and test results are provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. Long-term storage under inert atmosphere (e.g., nitrogen or argon) is recommended for optimal stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.